Patients suffering from lupus get relief with RituximabRituximab, which is currently indicated to patients suffering from cancer, can also prove effective for providing relief to patients with lupus and suffering from complications of the central nervous system, as per rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria.

Lupus is an immune system disorder that characterizes an attack by the human body on itself leading to diffused damage to several body organs besides resulting in inflammation and pain.

Clinical professor Michael Neuwelt, at the University of California San Francisco and Stanford University, said that Rituximab proves effective and may be classified as a gentler treatment form, which can last up to six months with a low risk of any side effect.